Back to Journals » Neuropsychiatric Disease and Treatment » Volume 2 » Issue 1

Mirtazapine in the treatment of essential tremor: an open-label, observer-blind study

Authors Davide Uccellini, G Grampa, I La Spina, D Nasuelli, I Neromante, L Politini, F Reverberi, D Porazzi, V Carli, G Camardese

Published 15 March 2006 Volume 2006:2(1) Pages 95—100


Davide Uccellini1, G Grampa1, I La Spina1, D Nasuelli1, I Neromante1, L Politini1, F Reverberi1, D Porazzi1, V Carli2, G Camardese2
1UO di Neurologia, AO “Ospedale di Circolo di Busto A”, Busto Arsizio Varese, Italy; 2Istituto di Psichiatria e Psicologia dell’Università Cattolica del Sacro Cuore, Roma, Italy
Introduction: Essential tremor (ET) is the most common movement disorder in the adult population. At present ET treatment shows limited efficacy, particularly in patients with severe and disabling symptoms. This study evaluates the clinical efficacy of mirtazapine in an untreated ET patient population.
Keywords: essential tremor, postural tremor, action tremor, mirtazapine, treatment, transcranial magnetic stimulation

Download Article [PDF]